What are skin quality injections?
Skin boosters is a broad term for injections intended to support hydration, texture and some fine lines. The Turkish expression sometimes translated as “youth vaccine” does not mean an immunisation vaccine. It describes neither one product nor a standard protocol.
Products with similar names can have different ingredients, approved uses, evidence and risks. This page particularly addresses hyaluronic acid-based skin quality injections while explaining differences from other products.
What can improve, and what are the limits?
Some hyaluronic acid products aim to improve hydration, smoothness and fine lines. Their water-binding properties contribute, but response depends on formulation, treatment and starting skin condition.
Small randomised studies have reported improvements in selected hydration or texture measures. Not every outcome improved, and some comparisons found no difference in elasticity. Findings cannot be applied to every product.
Marked laxity, deep volume loss, muscle-related wrinkles and pigment disorders are different problems. These injections do not produce a surgical facelift, permanent tightening or removal of all wrinkles.
Are hyaluronic acid, mesotherapy, PN and PDRN the same?
Hyaluronic acid formulations differ in concentration, cross-linking and added ingredients. A volumising filler and a skin quality product are not interchangeable. Mesotherapy describes multiple small injections, not one ingredient; more ingredients do not by themselves prove greater benefit.
Polynucleotides and PDRN are different from hyaluronic acid and are not automatically equivalent to each other. Limited product- and region-specific studies cannot establish identical effects throughout the face.
The product name, full composition, suitability for injection and instructions for the intended site matter. Evidence for one formulation must not be transferred to another.
Who might consider treatment?
Adults with reduced hydration, surface roughness or fine lines may be assessed within the product’s use and age limits. Dry skin does not automatically require injections; skin disease, skincare and expectations should be reviewed first.
I assess volume loss and laxity as well as skin quality. If the desired change cannot reasonably be achieved with the proposed method, this should be explained before treatment.
What should you report?
Report skin sensitivity, acne or infection, previous injections and fillers, all medicines and supplements, allergies, cold sores, immune conditions or treatments and previous complications.
Do not stop prescribed medication yourself. Active infection or inflammatory disease may require postponement; a known ingredient allergy excludes that product. Safety information in pregnancy and breastfeeding is insufficient, so elective aesthetic injections are better deferred.
How are skin boosters injected?
After assessment and cleaning, small amounts are injected using a technique and depth appropriate for the actual product and site. Distribution, quantity and pain control are individual. Needle pricks, stinging and tenderness can occur.
Area, injection number and preparation determine duration; there is no universal number of minutes or millilitres. Use on the neck, décolletage, hands or around the eyes must be assessed for the specific product rather than assumed from facial use.
How many sessions are needed, and how long does the effect last?
Sessions and intervals depend on instructions, skin needs, response and tolerance. Multiple-session research protocols are not a prescription for every patient.
Immediate fullness or brightness may partly reflect fluid and swelling. Results should be reviewed after early swelling settles, at the time appropriate for the product. Permanent rejuvenation or a fixed duration is not guaranteed. Repeat treatment depends on present benefit and skin findings, not the calendar alone.
Daily activities and skincare
If all is well, light daily activities can resume after treatment, although redness, bumps, swelling or bruising may be visible. Return to activity does not mean an invisible recovery.
Strenuous exercise, excessive heat and alcohol are generally limited initially; product-specific instructions take priority. Avoid touching with unclean hands, forceful massage or pressure unless instructed. Do not cover open injection points with makeup.
Agree when to resume active skincare and other injections, peels or lasers. Continue suitable skincare and sun protection. Increasing redness, pain, hard lumps or discharge need review; urgent signs should not wait.
How do these injections differ from toxin, filler and surgery?
Treatment follows the problem being addressed. No treatment, skincare changes and management of skin disease are options. Botulinum toxin targets muscle-related lines; volumising filler targets shape and support.
Significant facial and neck laxity may need assessment for surgery. Skin quality injections are not equivalent. Combined treatments require separate decisions about necessity, sequence, intervals and total risk.
Risks and unwanted outcomes
Every medical intervention, procedure and operation carries risks. Depending on the treatment and individual health, these may include death, disability and temporary or permanent unwanted functional or aesthetic outcomes.
No medical intervention, procedure or operation guarantees the result or results a patient wishes to achieve.
The following particularly concerns injected hyaluronic acid. Other ingredients may have additional or different risks and require product-specific counselling.
Pain, bruising and swelling
Stinging, redness, itching, tenderness, bruising and small bumps may occur. Persistent or increasing swelling or lumps must be assessed rather than assumed normal.
Infection and delayed reactions
Infection, abscesses, draining wounds and inflammatory nodules can develop, including delayed reactions. Medicines, drainage or other treatment may be needed.
Appearance and texture changes
Asymmetry, insufficient or excessive effect, firm areas, surface irregularity, prolonged oedema and colour change can occur. Superficial product may appear blue-grey. Unwanted changes or scars may persist.
Vascular occlusion and permanent harm
Material entering a vessel or impairing circulation can cause necrosis. Rare but serious visual impairment, blindness and stroke have been reported after facial injections. Small quantities and the term “booster” do not remove this risk.
Allergy and systemic reactions
The product, added ingredients or anaesthetic can cause allergy. Anaphylaxis can be life-threatening and requires emergency treatment.
Further treatment and limits
Medicines, imaging, hospital care or surgery may be required. Hyaluronidase may be considered for suitable hyaluronic acid products; it does not dissolve every skin booster and can itself cause allergy. Permanent injury can remain despite treatment.
When should you seek urgent help?
Contact the treating clinician immediately for unusual or increasing pain, skin blanching, a net-like purple pattern, cold skin or marked colour changes. Do not dismiss these as ordinary bruising.
For sudden visual change, loss of vision, speech problems, facial or limb weakness, breathing difficulty, tongue/throat swelling or fainting, call 112 or attend emergency care and report the recent injection.
This information does not replace an individual examination and informed consent discussion. Reading this page does not constitute consent to treatment or to publication of photographs. Other individual or unforeseen risks may apply.
Frequently asked questions
Is a “youth vaccine” a real vaccine?
No. This is a colloquial Turkish term for different skin quality injections, not immunisation.
Is it a filler, and will my face swell?
Some contain hyaluronic acid but have a different aim from volumising filler. Temporary swelling can occur; product, quantity and depth influence appearance.
Does it work like botulinum toxin?
No. Botulinum toxin targets muscle-related lines. Skin quality injections do not reduce muscle movement in the same way.
Is it the same as “salmon DNA”?
No. Full composition must be checked. Polynucleotides, PDRN and hyaluronic acid are not interchangeable.
How many sessions must I have?
There is no mandatory universal number. Product instructions, need, response and tolerance determine the plan.
Is first-day brightness the final result?
No. Injection fluid and swelling can affect the early appearance; assess at an appropriate follow-up.
How long does it last?
There is no single duration. Ingredient, protocol and skin matter. Results are not permanent; repeat treatment is individually assessed.
Will it lift sagging skin?
It does not correct significant skin and deeper tissue laxity like a facelift. Better hydration is different from surgical repositioning.
Will pigmentation and pores disappear?
Complete removal cannot be promised. Pigment disorders need diagnosis; improved pore measurements do not mean permanent pore closure.
Does treatment hurt?
Needle pricks, stinging and tenderness can occur. Appropriate local comfort measures may be used; completely painless treatment is not guaranteed.
Can I return to work?
Light work may be possible if all is well. Visible redness, bumps or bruising should be considered before important events.
When can I wear makeup or exercise?
Do not apply makeup to open injection points. Strenuous activity and heat are generally limited initially; follow the product-specific care plan.
Can I have it during pregnancy or breastfeeding?
Safety data are insufficient. Elective aesthetic injections are better postponed.
Can it all be dissolved if I dislike it?
Not every ingredient can be dissolved. Hyaluronidase is considered only for suitable hyaluronic acid; it cannot guarantee reversal of every tissue reaction.
Will stopping make my skin worse?
The supported appearance may decline as the effect wears off and ageing continues. Persistent swelling, nodules or other problems require separate assessment.
What affects the cost?
The product, amount, treated area, sessions and follow-up affect cost. Similar treatment names can conceal different products and quantities. Ask for the product name, quantity, review arrangements and total plan before comparing prices.
Sources
This patient information is based on the current Turkish page, the surgeon’s stated practice and the sources below. Study findings apply to the products, techniques and populations studied; they do not guarantee an individual result. Reviewed: 29 October 2026.
FDA documents describe a particular product or general safety framework. They do not mean this practice uses that product or that all skin boosters have the same authorisation.
- Duteil et al. — Non-cross-linked hyaluronic acid versus saline: randomised split-face study, 2023 ↗
- Rutnumnoi et al. — Superficial hyaluronic acid injections for skin quality and pores, 2025 ↗
- Lee et al. — Polynucleotide versus hyaluronic acid in the periocular region, 2022 ↗
- FDA — Patient information for a specific hyaluronic acid skin-quality product, 2026 ↗
- FDA — Dermal filler safety and vascular complications ↗
- AAD — Preparation for filler treatment ↗
- ASPS — Dermal filler risks and safety ↗
